ES8604744A1 - Anti-thrombin III prepn. - Google Patents

Anti-thrombin III prepn.

Info

Publication number
ES8604744A1
ES8604744A1 ES535617A ES535617A ES8604744A1 ES 8604744 A1 ES8604744 A1 ES 8604744A1 ES 535617 A ES535617 A ES 535617A ES 535617 A ES535617 A ES 535617A ES 8604744 A1 ES8604744 A1 ES 8604744A1
Authority
ES
Spain
Prior art keywords
prepn
thrombin iii
thrombin
iii
pasteurising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535617A
Other languages
Spanish (es)
Other versions
ES535617A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Landerlan SA
Original Assignee
Laboratorios Landerlan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Landerlan SA filed Critical Laboratorios Landerlan SA
Priority to ES535617A priority Critical patent/ES8604744A1/en
Publication of ES535617A0 publication Critical patent/ES535617A0/en
Publication of ES8604744A1 publication Critical patent/ES8604744A1/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Anti-thrombin (III) is prepared from human plasma from which the cryo-precipitate and pro-thrombotic complex has been previously separated, by (a) extracting semi-purified anti-thrombin III with aluminium hydroxide gel; (b) pasteurising for 10 hours at 60 deg.C in presence of 0.5 M citrate of pH 8.3; and
ES535617A 1984-09-03 1984-09-03 Anti-thrombin III prepn. Expired ES8604744A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES535617A ES8604744A1 (en) 1984-09-03 1984-09-03 Anti-thrombin III prepn.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES535617A ES8604744A1 (en) 1984-09-03 1984-09-03 Anti-thrombin III prepn.

Publications (2)

Publication Number Publication Date
ES535617A0 ES535617A0 (en) 1985-11-01
ES8604744A1 true ES8604744A1 (en) 1985-11-01

Family

ID=8487832

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535617A Expired ES8604744A1 (en) 1984-09-03 1984-09-03 Anti-thrombin III prepn.

Country Status (1)

Country Link
ES (1) ES8604744A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094701A1 (en) * 1995-07-12 1997-01-16 Grifols Grupo Sa Process for the production of antithrombin III

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094701A1 (en) * 1995-07-12 1997-01-16 Grifols Grupo Sa Process for the production of antithrombin III

Also Published As

Publication number Publication date
ES535617A0 (en) 1985-11-01

Similar Documents

Publication Publication Date Title
AU594488B2 (en) Agents for the treatment of arthroses
AU4297685A (en) Compositions for the allevation, treatment and diagnosis of arthritic disease and related conditions
ZA869402B (en) Process for the preparation of(2,2)-paracyclophane and derivatives thereof
AU591216B2 (en) Ultrasonic surgical apparartus
SI0960109T1 (en) Process to prepare tolterodine
IE860077L (en) Glycosidic derivatives
GR3005035T3 (en)
AU8790782A (en) Elliptical suturing cuff
HUT39454A (en) Process for preparing derivatives of glycero-phosphocholine and glycero-phospho-ethanolamine
AU587648B2 (en) Process for the preparation of (2,2)- paracyclophane
DE3565935D1 (en) Composition for accelerating recovery of function of hematopoietic organs and the use thereof
CA2165329A1 (en) Process for the preparation of n-acetyl neuraminic acid derivatives
ES8203914A1 (en) Process for obtaining human relaxin from fetal membranes
EP0118246A3 (en) Material for use in the treatment of spontaneous abortions
ES8604744A1 (en) Anti-thrombin III prepn.
AU6393686A (en) Process for preparing halogen magnesium alanate and use thereof
AU8247187A (en) Plant male sterilant
GR3001691T3 (en) Novel crystalline salts of aryloxy-propanolamines, their preparation and their use
GR3005736T3 (en)
EP0207505A3 (en) Use of a prenyl ketone in the preparation of a medicament against gastritis
ES2052105T3 (en) GILANTHENE: ANTI-METASTATIC PRINCIPLE OF SANGUIJUELA OF SOUTH AMERICA HAEMENTARIA GHILIANII.
HK88396A (en) 24r-scymnol and preparation and use thereof
AU4600689A (en) Process for separating copper from aqueous base
MY101535A (en) Pharmaceutical compositions
AU590431B2 (en) A method for the preparation of 2,4-diamino-3-oxy-6- piperidyl-pyrimidine